•
Jun 30, 2023

Wyndham Q2 2023 Earnings Report

Wyndham's Q2 2023 results reflected solid global RevPAR growth and strategic pipeline expansion.

Key Takeaways

Wyndham Hotels & Resorts reported a solid second quarter in 2023, marked by a 7% growth in global RevPAR and a 4% increase in system-wide rooms. The development pipeline expanded by 10% year-over-year, and the company successfully refinanced its Term Loan B Facility. The Board of Directors approved a $400 million increase in share repurchase authorization.

Global RevPAR increased by 7% compared to Q2 2022 in constant currency.

System-wide rooms grew by 4% year-over-year.

The development pipeline expanded by 10% year-over-year.

Share repurchase authorization increased by $400 million.

Total Revenue
$362M
Previous year: $386M
-6.2%
EPS
$0.93
Previous year: $1.07
-13.1%
Global RevPAR
$46.5
Previous year: $44.3
+4.9%
Total Rooms
851.5K
Previous year: 818.9K
+4.0%
Gross Profit
$198M
Previous year: $221M
-10.4%
Cash and Equivalents
$63M
Previous year: $400M
-84.3%
Free Cash Flow
$74M
Previous year: $99M
-25.3%
Total Assets
$4.06B
Previous year: $4.25B
-4.6%

Wyndham

Wyndham

Wyndham Revenue by Segment

Forward Guidance

The Company is refining its outlook as follows:

Positive Outlook

  • Year-over-year rooms growth: 2 - 4%
  • Year-over-year global RevPAR growth: 4 - 6%
  • Fee-related and other revenues: $1.38 - $1.41 billion
  • Adjusted EBITDA: $654 - $664 million
  • Free cash flow conversion rate: 50 - 55%

Challenges Ahead

  • Reduction in adjusted net income represents an increase in interest expense due, in part, to the refinancing of the Company's Term Loan B.
  • Adjusted net income: $336 - $348 million
  • Adjusted diluted EPS: $3.92 - $4.06
  • Year-over-year growth rates are not comparable due to the sale of the Company's owned hotels and the exit of its select-service management business, both of which occurred during 2022, as well as the variability in its marketing funds
  • The Company's expectations for full-year 2023 marketing funds contribution to adjusted EBITDA is unchanged at $10 million.